Vericel Corp (VCEL)

50.97 -0.32  -0.62% NASDAQ Oct 25, 16:00 50.99 +0.02  +0.04% After-Hours: 20:00 USD
View Full Chart
Price Chart
View All VCEL News

News

View All Events

Events

Date Type Description
11/09/2021 Earnings Results Q3 2021 Earnings Results
11/09/2021 08:30 EST Earnings Calls Q3 2021 Earnings Call
08/04/2021 Earnings Results Q2 2021 Earnings Results
08/04/2021 08:30 EST Earnings Calls Q2 2021 Earnings Call
05/05/2021 Earnings Results Q1 2021 Earnings Results
05/05/2021 08:30 EST Earnings Calls Q1 2021 Earnings Call
04/28/2021 09:00 EST AGM 2020 Annual General Meeting
02/24/2021 Earnings Results Q4 2020 Earnings Results
02/24/2021 08:30 EST Earnings Calls Q4 2020 Earnings Call
11/05/2020 08:30 EST Earnings Calls Q3 2020 Earnings Call
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company dedicated to the identification, development, and commercialization of innovative therapies that enable the body to repair and regenerate damaged tissues and organs to restore normal structure and function. Vericel has marketed products and the goal is to become the leader in cell therapy and regenerative medicine by developing, manufacturing and marketing best-in-class therapies for patients with significant unmet medical needs. The Company operates in one reportable segment: the research, product development, manufacture and distribution of patient-specific, expanded cellular therapies for use in the treatment of specific diseases.
  • URL: https://www.vcel.com
  • Investor Relations URL: https://investors.vcel.com/
  • HQ State/Province: Massachusetts
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Growth
  • Next Earnings Release: Nov. 09, 2021
  • Last Earnings Release: Aug. 04, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Top Fund Holders

Symbol Name Weighting
PBE Invesco Dynamic Biotech & Genome ETF 2.72%
WSGBX Delaware Ivy Small Cap Growth B 2.34%
WEMCX Wells Fargo Emerging Growth C 2.30%
CSSSX Carillon Scout Small Cap R-5 2.30%
BCSIX Brown Capital Mgmt Small Co Inv 2.09%
PSCH Invesco S&P SmallCap Health Care ETF 1.88%
SBIO ALPS Medical Breakthroughs ETF 1.39%
MAGKX Mutual of America Small Cap Growth 0.99%
UISCX USAA Small Cap Stock Institutional 0.58%
GSSC Goldman Sachs ActiveBeta® US SmCp Eq ETF 0.23%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.